A new trading day began on Friday, with Sabra Healthcare REIT Inc (NASDAQ: SBRA) stock price down -3.92% from the previous day of trading, before settling in for the closing price of $19.40. SBRA’s price has ranged from $12.83 to $19.73 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Real Estate sector was 1.01%. Meanwhile, its annual earnings per share averaged 783.33%. With a float of $232.71 million, this company’s outstanding shares have now reached $236.59 million.
Considering the fact that the conglomerate employs 48 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 45.12%, operating margin of 38.36%, and the pretax margin is 16.09%.
Sabra Healthcare REIT Inc (SBRA) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the REIT – Healthcare Facilities Industry. The insider ownership of Sabra Healthcare REIT Inc is 1.64%, while institutional ownership is 91.28%. The most recent insider transaction that took place on May 22 ’24, was worth 101,010. In this transaction Director of this company bought 7,000 shares at a rate of $14.43, taking the stock ownership to the 46,385 shares. Before that another transaction happened on May 14 ’24, when Company’s Director sold 10,000 for $14.68, making the entire transaction worth $146,830. This insider now owns 63,923 shares in total.
Sabra Healthcare REIT Inc (SBRA) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 783.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 68.42% during the next five years compared to -47.68% drop over the previous five years of trading.
Sabra Healthcare REIT Inc (NASDAQ: SBRA) Trading Performance Indicators
Here are Sabra Healthcare REIT Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of N/A. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.12. Likewise, its price to free cash flow for the trailing twelve months is 13.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.41, a number that is poised to hit 0.16 in the next quarter and is forecasted to reach 0.68 in one year’s time.
Technical Analysis of Sabra Healthcare REIT Inc (SBRA)
Compared to the last year’s volume of 2.05 million, its volume of 3.18 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 59.12%. Additionally, its Average True Range was 0.42.
During the past 100 days, Sabra Healthcare REIT Inc’s (SBRA) raw stochastic average was set at 79.91%, which indicates a significant increase from 29.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 25.25% in the past 14 days, which was higher than the 22.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.20, while its 200-day Moving Average is $15.51. Nevertheless, the first resistance level for the watch stands at $19.46 in the near term. At $20.28, the stock is likely to face the second major resistance level. The third major resistance level sits at $20.78. If the price goes on to break the first support level at $18.14, it is likely to go to the next support level at $17.64. Now, if the price goes above the second support level, the third support stands at $16.82.
Sabra Healthcare REIT Inc (NASDAQ: SBRA) Key Stats
With a market capitalization of 4.24 billion, the company has a total of 234,264K Shares Outstanding. Currently, annual sales are 647,510 K while annual income is 13,760 K. The company’s previous quarter sales were 176,140 K while its latest quarter income was 23,980 K.
